Dr. Plasse has over 30 years of experience in pharmaceutical development. He has managed clinical studies from phase 1 through 4, including many first-in-man studies, and has extensive experience interacting with the FDA at all stages of development. He has hands-on experience from pre-IND through approval stages of drug and biologic development, and has been involved in the development of a number of drugs for a variety of indications including Taxotere, Iressa, Zolinza, and Erbitux. As a consultant to the industry for over 15 years, he has helped many companies, both large and small, move products through clinical development and through the regulatory process including Rhone-Poulenc Rorer, Astra-Zeneca, Merck, and Bristol-Meyers Squibb.
Terry Plasse, MD
Chief Medical Officer